| Scorecard |
|---|
|
3 / 5 Stars
|
|
Lipper
4
5
2
5
3
|
|
Zacks Investment Research
5
(Strong Sell)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
D-
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 2.74 | 2.74 |
| Stocks | 0.66 | 0.66 |
| Bonds | 2.52 | 2.52 |
| Other | 0.13 | 0.13 |
| Foreign Bonds | 0.35 | 0.35 |
| Foreign Stocks | 93.6 | 93.6 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| T. Rowe Price Short-Term Bond | --- | --- | 3.56 |
| Royal Dutch Shell PLC ADR Class B | RDS.B | -0.37 | 2.67 |
| Nestle SA | NSRGF | 9.65 | 2.59 |
| Novartis AG | NVSEF | 17.5 | 2.36 |
| Sanofi | SAN | --- | 2.25 |
| Vodafone Group PLC ADR | VOD | 21.24 | 1.71 |
| Bayer AG | BAYN | --- | 1.64 |
| Eni SpA | ENI | --- | 1.61 |
| GlaxoSmithKline PLC ADR | GSK | 20.06 | 1.6 |
| AIA Group Ltd. | AAIGF | --- | 1.49 |
Bond Ratings (%)
Updated 03.31.2013
| Sector | TRIGX |
|---|---|
| AAA | 45.55 |
| AA | 8.15 |
| A | 16.53 |
| BBB | 28.76 |
| BB | 0.95 |
| B | 0.04 |
| Below B | 0.02 |
| Other | 0.0 |
